US Patent

US10220155 — Syringe device with a dose limiting mechanism and an additional safety mechanism

Formulation · Assigned to Novo Nordisk AS · Expires 2026-07-17 · 0y remaining

Vulnerability score 43/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a syringe device with mechanisms to prevent the ejection of a dose exceeding a set dose, including a safety mechanism in case of failure.

USPTO Abstract

A syringe device for ejecting a dose of a medicament, the syringe device comprising: a dose limiting mechanism arranged to interact with a dose ejecting mechanism to prevent ejection of a dose exceeding a set dose, and a safety mechanism, which is arranged such with respect to the dose ejecting mechanism that, if the dose limiting mechanism fails, the safety mechanism prevents ejection of a dose exceeding the set dose.

Drugs covered by this patent

Patent Metadata

Patent number
US10220155
Jurisdiction
US
Classification
Formulation
Expires
2026-07-17
Drug substance claim
No
Drug product claim
Yes
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.